Devin Parekh, who has co-run Insight Partners for 26 years, said the firm prefers portfolio performance over public commentary as it invests across early-stage, growth, buyout and secondary transactions. Insight manages $90 billion and has led or co-led numerous Databricks rounds while holding stakes in OpenAI and Anthropic. Parekh said AI's potential benefits in health care outweigh risks, citing analysis of 50 million patient records that identified a 25% heart-attack risk for some people. He warned that venture valuations are rising at a pace reminiscent of 2021, with follow-on rounds sometimes delivering higher prices without meaningful new data. Insight has not completed a major buyout since 2024, while its strongest returns have come from doubling down on winners such as Wiz. Parekh described AI infrastructure talent as concentrated in San Francisco but said vertical applications such as financial-services software remain geographically broader. He defended later-stage investments in competing companies such as OpenAI and Anthropic, while saying early-stage investors face information-sharing restrictions and generally avoid direct competitors. Parekh also urged fund managers to prioritize liquidity, saying Insight returned more than $20 billion to limited partners through strategic sales and IPOs over the last two years, with several billion dollars more expected. He expects more AI IPOs over the next 18 months but said long-term venture returns still favor diversification, disciplined liquidity and identifying strong founders in attractive markets.